Skip to content
Recall Observatory FDA recall evidence

Device product

IgM Immunoturbidimetric Assay-In vitro determination of IgA and IgM in serum and plasma Catalog Number: IM3834

Z-0363-2023

November 01, 2022

Class II

Product summary

Firm
Randox Laboratories Ltd.
Event
Event 91097
Status
Terminated
Classification
Class II
Quantity
20 kits US in total
Official record key
device-enforcement:Z-0363-2023

Official wording

Reason: Update to the carryover avoidance technical bulletin to detail that IgA and IgM assays should not be run immediately after Fructosamine Catalogue Number FR3133 or FR4030 on the RX instruments testing order. Can lead to an elevation in Quality Control and Patient results of up to +13% for lgA and +51% for lgM respectively, which may lead to a delay in running patient samples or erroneous elevated test results

Code information: GTIN: 05055273204001 All lots

Distribution pattern: US Nationwide Distribution: CA, NC, NJ and WV,

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Update to the carryover avoidance technical bulletin to detail that IgA and IgM assays should not be run immediately after Fructosamine Catalogue Number FR3133 or FR4030 on the RX instruments testing order. Can lead to an elevation in Quality Control and Patient results of up to +13% for lgA and +51% for lgM respectively, which may lead to a delay in running patient samples or erroneous elevated test results